Cancer Biomarkers Market Prognostic Insights for Personalized Oncology Care 2024-2031 | Merck KgaA, QIAGEN N.V
cancer biomarkers market is estimated to be valued at USD 25.60 Bn in 2024 and is expected to reach USD 59.01 Bn by 2031, exhibiting a (CAGR) of 12.7% BURLINGAME, CALIFORNIA , UNITED STATES, May 23, 2024 /EINPresswire.com/ -- Market Overview: …